Masimo softFlow™
Nasal High Flow Therapy for Spontaneously Breathing Adult Patients in Hospital and Long-Term Care Facilities
Nasal High Flow Therapy for Spontaneously Breathing Adult Patients in Hospital and Long-Term Care Facilities
Masimo softFlow™
Respiratory support delivered through a soft nasal cannula interface
Wide flow range from 10-60 L/min* in 0.5 L/min steps to permit flow rate to be tailored to the specific needs of the patient
Ability to supplement oxygen with 0-60 L/min flow and up to 100% FiO2 from wall supply, oxygen cylinder, or concentrator
Integrated flow driver provides flow without the need for wall air supply
Warmed humidification of respiratory gas all the way to the patient’s nose to enhance therapy comfort and aid in mucous clearance¹, ²
Condensate-free delivery of a consistent, high-velocity flow during inspiration and exhalation
Auto-identification of type of nasal cannula and breathing circuit to improve and simplify workflow through automated configuration
Bacterial/viral filter between device and patient, rather than between device and room air, to reduce risk of cross-contamination
References:
¹ Hasani, A et al. Chron Respir Dis 5, no. 2 (2008): 81-86.
² Roca, O et al. Respir Care 55, no. 4 (2010): 408-413.
* The softFlow is FDA cleared for flow rates up to 50 L/min and in hospital and long-term care facilities. The 60 L/min version and the home use version are being made available in the US under the FDA Enforcement Policy for Ventilators and Accessories and Other Respiratory Devices During the COVID-19 Public Health Emergency.
Available in Small, Standard, Standard-Plus, and Large sizes
Unique one-piece design permits heater wire all the way to the nares to reduce condensation